The invention relates to compounds of formula (I) having pharmacological activity towards the sigma receptor, to processes of preparation of such compounds, to pharmaceutical compositions comprising them, and to their use for the treatment and or prophylaxis of a disease in which the sigma receptor is involved. ##STR00001##

 
Web www.patentalert.com

< Antagonists to melanin-concentrating hormone receptor comprising benzimidazole derivative as active ingredient

> Bicyclic sulfonamide derivatives which are L-CPT1 inhibitors

> Modulators of muscarinic receptors

~ 00597